EAM Global Investors »

Bridgebio Pharma shares owned by EAM Global Investors

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by EAM Global Investors from 13F filings

Historical chart of EAM Global Investors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by EAM Global Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by EAM Global Investors

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.7M 142k 26.37
2023-06-30 $3.8M 223k 17.20
2023-03-31 $3.7M 223k 16.58

More positions owned by EAM Global Investors

MINISO Group Holding Common Stock (MNSO)
Vista Energy SAB de CV Common Stock (VIST)
Stantec Common Stock (STN)
NexGen Energy Common Stock (NXE)
EMCOR Group Common Stock (EME)
Onto Innovation Common Stock (ONTO)
Vertiv Holdings Common Stock (VRT)
Jabil Common Stock (JBL)
Celestica Common Stock (CLS)
FTAI Aviation Common Stock (FTAI)
First Citizens BancShares Common Stock (FCNCA)
Owens Corning Common Stock (OC)
Comfort Systems USA Common Stock (FIX)
Tidewater Common Stock (TDW)
Celsius Holdings Common Stock (CELH)

View all positions for EAM Global Investors

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma